Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway
Authors:
- 11 July 2022
- journal article
- research article
- Published by Springer Nature in Human Cell
- Vol. 35 (5) , 1521-1534
Abstract
Colon cancer is one of the most prevalent malignant tumors across the world. Increasing studies have demonstrated that long non-coding RNAs (lncRNAs) take part in colon cancer development. Our study intends to explore the expression characteristics of LBX2-AS1, a novel lncRNA, in colon cancer and its underlying mechanisms. The results illustrated that LBX2-AS1 level was substantially increased in colon cancer tissues and was obviously correlated with the tumor volume and early distant metastasis of patients. Besides, overexpression of LBX2-AS1 remarkably boosted growth, proliferation, and metastasis and restrained apoptosis in colon cancer cells, whereas LBX2-AS1 knockdown produced the opposite effect. On the other hand, miR-627-5p, down-regulated in colon cancer tissues, was negatively associated with LBX2-AS1 expression. Functional experiments showed that miR-627-5p suppressed colon cancer growth. Mechanistically, LBX2-AS1, as an endogenous competitive RNA, targeted miR-627-5p and restrained its expression, while miR-627-5p targeted and negatively regulated the RAC1/PI3K/AKT axis. Collectively, this study has revealed that LBX2-AS1 is a poor prognostic factor of colon cancer and can regulate colon cancer progression by regulating the miR-627-5p/RAC1/PI3K/AKT pathway.Keywords
Funding Information
- Huazhong University of Science and Technology “Double Top” Construction Project of International Cooperation (540-5001540013)
- Wuhan Municipal Health Commission (WX18C03)
- Wuhan Municipal Health Commission (WX12B08, WX19D65)
This publication has 35 references indexed in Scilit:
- Negative regulation of TGF-β1-induced MKK6-p38 and MEK-ERK signalling and epithelial-mesenchymal transition by Rac1bScientific Reports, 2017
- miR-378 suppresses the proliferation, migration and invasion of colon cancer cells by inhibiting SDAD1Cellular & Molecular Biology Letters, 2017
- A cytokine signal inhibitor for rheumatoid arthritis enhances cancer metastasis via depletion of NK cells in an experimental lung metastasis mouse model of colon cancerOncology Letters, 2017
- LncRNA-mediated regulation of cell signaling in cancerOncogene, 2017
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseasesNature Reviews Drug Discovery, 2017
- Adjuvant chemotherapy for colon cancer: the difference between Japanese and western strategiesExpert Opinion on Pharmacotherapy, 2016
- miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancerOncology Reports, 2015
- miRNA as markers for the diagnostic screening of colon cancerExpert Review of Anticancer Therapy, 2014
- A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cellsOncogene, 2011
- Activation of Rac1-PI3K/Akt is required for epidermal growth factor-induced PAK1 activation and cell migration in MDA-MB-231 breast cancer cellsJournal of Biomedical Research, 2011